title: [Co-morbidity and mortality during the first year of life in children with jejunoileal atresia].
abstract: OBJECTIVE
  To identify the co-morbidity and mortality during the first year of life in children with jejunoileal atresia.
  
  
  METHODS
  Descriptive, comparative cohort. SITE: Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.
  
  
  METHODS
  Seventy children with jejunoileal atresia.
  
  
  METHODS
  Following variables were registered: gestational age, birth weight, sex, type and site of atresia, other congenital defects, surgical management, number of surgeries, duration of fasting, re-hospitalizations, weight and height at 6 months and one year of life, co-morbidity and mortality.
  
  
  RESULTS
  Intestinal atresia types I and II were present in 27% of the patients respectively and type IIIa in 24%. Co-morbidity in the neonatal period was 64.2%, being the most common conditions sepsis (47.1%) and anastomotic stricture (18.5%). During the first year of life co-morbidity was 51.4%, presented as functional intestinal obstruction (21.4%). Mortality was 11.4% (n = 8), the main causes of death were sepsis (n = 6) and liver failure (n = 2). The mortality rate according to the type of atresia was 44.4% for type IV, 33.3% for type IIIb and 1.3% for type I.
  
  
  CONCLUSIONS
  Co-morbidity during the first year of life in children with jejunoileal atresia is high, and related to infections and anastomosis inherent problems. Mortality is higher for intestinal atresia type IV.
authors.affiliation: Unidad de Cuidados Intensivos Neonatales, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS. hely1802@yahoo.com.mx
authors.forename: Heladia
authors.initials: H
authors.lastname: García
authors.forename: Mario
authors.initials: M
authors.lastname: Franco-Gutiérrez
authors.forename: Evaldo Jesús
authors.initials: EJ
authors.lastname: Rodríguez-Mejía
authors.forename: Carlos David
authors.initials: CD
authors.lastname: González-Lara
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007409:Intestinal Atresia / Q000150:complications* / Q000401:mortality*; D007583:Jejunum / Q000002:abnormalities*; D008297:Male